ÀÏÁ¤Ç¥

  • - ÀϽÃ: 2024³â 9¿ù 21ÀÏ(Åä) 08:50-17:10
  • - Àå¼Ò: ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼ÇȦ
  • - ÆòÁ¡: ´ëÇÑÀÇ»çÇùȸ 6ÆòÁ¡
08:00-08:50 µî·Ï  
08:50-09:00 Opening Remark  

´ëÇÐȸÀå(ÄÁº¥¼ÇȦ)

Session¥° New Biological Targets for Sarcopenia
ÁÂÀå: ÀÌÀ±½Ç(¼­¿ï´ëÇб³), ÀÌÇö½Â(Ãæ³²ÀÇ´ë)
09:00-09:30 Finding Biomarkers for Sarcopenia and Their Applications: An Introduction with Examples ·ùµ¿·Ä ±³¼ö(±¤ÁÖ°úÇбâ¼ú¿ø)
09:30-10:00 Combinatorial TGFb and Dystrophin Antisense Oligonucleotide Therapy Enhances Muscle Regeneration and Dystrophin Restoration in Serve Model of Duchenne Muscular Dystrophy ¹®¿µÀç ±³¼ö(ÀüºÏÀÇ´ë)
10:00-10:30 MicroRNA as a Therapeutic Target for Sarcopenia À̱¤Ç¥ ¹Ú»ç(Çѱ¹»ý¸í°øÇבּ¸¿ø)
10:30-10:45 Coffee Break  
Session ¥± Lessons from Neuromuscular and Inflammatory Muscular Disease
ÁÂÀå: ±èųâ(ÀÎÁ¦ÀÇ´ë), ±èÅ¿µ(°Ç±¹ÀÇ´ë)
10:45-11:10 Muscle Pathology in Neuromuscular Disorders ¹Ú¿µÀº ±³¼ö(ºÎ»ê´ëÇб³º´¿ø)
11:10-11:35 ½Å°æ°ú Áúȯ¿¡¼­ ¹Ù¶óº¸´Â ±Ù°¨¼ÒÁõÀÇ Áø´Ü°ú Ä¡·á ¹ÚÇüÁØ ±³¼ö(°­³²¼¼ºê¶õ½ºº´¿ø)
11:35-12:00 ÀçÈ°ÀÇÇаú¿¡¼­ ¹Ù¶óº¸´Â ±Ù°¨¼ÒÁõÀÇ Áø´Ü°ú Ä¡·á À̺´Âù ±³¼ö(Áß¾ÓÀÇ´ë)
12:00-12:25 ·ù¸¶Æ¼½º³»°ú¿¡¼­ ¹Ù¶óº¸´Â ±Ù°¨¼ÒÁõÀÇ Áø´Ü°ú Ä¡·á(±ÙÀ°¿°ÀÇ Áø´Ü°ú Ä¡·á) ¹ÚÁØ¿ø ±³¼ö(¼­¿ï´ëÇб³º´¿ø)
12:25-12:40 Discussion  
12:40-13:30 Lunch  
Session ¥² ÀÚÀ¯¿¬Á¦
ÁÂÀå: ÀÓÀ翵(¼­¿ïÀÇ´ë), À¯ÁØÀÏ(ÀÎÇÏÀÇ´ë)
13:30-14:00 6°³ ÀÚÀ¯¿¬Á¦  
14:00-14:20 Discussion ¡¡
Session ¥³ Cutting-Edge Trends in Sarcopenia Diagnosis: A Global and Domestic Perspective
ÁÂÀå: ÀÌ¿µ±Õ(¼­¿ïÀÇ´ë), ÇÏ¿ëÂù(ºÎ¹Î º´¿ø)
14:20-14:50 GLIS µ¨ÆÄÀÌ Á¶»ç°á°ú(Sarcopenia Conceptual Definition, Frailty) ±è¹ÌÁö ±³¼ö(°æÈñÀÇ·á¿ø)
14:50-15:20 WHO ICOPE °üÁ¡À¸·Î ¹Ù¶óº¸´Â ±¹³» ±Ù°¨¼ÒÁõ/³ë¼è, Áö¿ª»çȸ ÁßÀç ¹æ¾È ÀÌÇýÁø ±³¼ö(ºÐ´ç¼­¿ï´ëÇб³º´¿ø)
15:20-15:35 Coffee Break ¡¡
Session V Overcoming Barriers to Treating Sarcopenia in Older Adults
ÁÂÀå: ¼Û¿í(¼­¿ï´ëÇб³), ÀÌÇØÁ¤(°¡Ãµ´ëÇб³)
15:35-16:00 ¿µ¾çÁßÀç ±Ç¹Ì¶ó ÀÓ»ó¿µ¾çÆÄÆ®Àå
(¼­¿ï´ëÇб³º´¿ø)
16:00-16:25 ¿îµ¿ÁßÀç ¹è¼º·ù ±³¼ö(µ¿¾Æ´ëÇб³)
16:25-16:50 ÀçÈ°ÁßÀç ¹üÀç¿ø ±³¼ö(ºÐ´ç¼­¿ï´ëÇб³º´¿ø)
16:50-17:10 Pannel Discussion ¹Ú¿ë¼ø(ÇѾç´ëÇб³)
±èâ¼±(µ¿´ö¿©ÀÚ´ëÇб³)
½Å¸íÁØ(ºÎ»êÀÇ´ë)

¼ÒÇÐȸÀå(´ëȸÀǽÇ)

Session VI Model Organisms for Muscle Research
ÁÂÀå: À̽ÂÈÆ(¿ø±¤´ëÇб³), ÀüÀçÇÑ(°æºÏ´ëÇб³)
09:00-09:30 How to Study Healthy Aging in C. Elegans ±èÁÖ¿ø(°Ç´ëÀÇ´ë)
09:30-10:00 Zebrafish Model to Study Muscle Biology ÃÖ¼º±Ô(¿ø±¤´ëÇб³)
10:00-10:30 Development of New Drugs for Sarcopenia Using Mouse Model: PROKR1-NR4A2 Axis for Oxidative Muscle Fiber Specification ¹ÚÁßÈÆ(¼­¿ï´ëÇб³)
10:30-11:00 Coffee Break ¡¡
Session ¥¶ ´ëÇѱٰ¨¼ÒÁõÇÐȸ & Çѱ¹¿îµ¿»ý¸®ÇÐȸ °øµ¿ ¼¼¼Ç(KSS & KSEP Joint Symposium): ±Ù°¨¼ÒÁõ¿¡ ´ëÇÑ ¿îµ¿ÀÇ ´Ù¾çÇÑ Á¢±Ù
ÁÂÀå: ±è´öÀ±(´ëÇѱٰ¨¼ÒÁõÇÐȸ ȸÀå), ÀÌÈ£¼º(Çѱ¹¿îµ¿»ý¸®ÇÐȸ ȸÀå)
11:00-11:30 ¼ö¸é Àå¾Ö ȯÀÚÀÇ ±Ù°¨¼ÒÁõ °³¼±À» À§ÇÑ ¿îµ¿ Àü·« °ø¼º¾Æ ±³¼ö
(¼º±Õ°ü´ëÇб³ »ï¼ºÀ¶ÇÕÀÇ°úÇпø)
11:30-12:00 ±Ù°ñ°Ý°è ÁúȯÀÚÀÇ ±Ù°¨¼ÒÁõ °³¼±À» À§ÇÑ ¿îµ¿ Àü·« ±èº´°ï ¹Ú»ç(K-ÇコÄÉ¾î ¿¬±¸¼Ò)
12:00-12:30 ½ÉÀåÁúȯ ȯÀÚÀÇ ±Ù°¨¼ÒÁõ ¿¹¹æ°ú °³¼±À» À§ÇÑ ¿îµ¿ Àü·« ¼­¿ë°ï ¹Ú»ç
(»ï¼º¼­¿ïº´¿ø ¿¹¹æÀçÈ°¼¾ÅÍ)
12:30-12:40 Discussion ¹× MOU Çà»ç ¡¡
Session ¥· Future Treatment Strategy for Sarcopenia
ÁÂÀå: ±Ç±â¼±(Çѱ¹»ý¸í°øÇבּ¸¿ø), ¹è±Ô¿î(¾Ö´Ï¸Ó½ºÅ¥¾î)
13:30-14:00 The Role of Korea Chemical Bank (KCB) in Discovering New Drugs during the Transition from Fast Mover to First Mover ÀÌ°èÇü ¼¾ÅÍÀå(Çѱ¹È­ÇÕ¹°ÀºÇà)
14:00-14:30 In Silico Platform for Bio-drug Development ÀÌ¿ø±Ô ¼±ÀÓ¿¬±¸¿ø
(¿À¼Û ½Å¾à°³¹ßÁö¿ø¼¾ÅÍ)
14:30-15:00 Non-shivering Thermogenesis: Its Potential Roles and Applications in Muscle Atrophy ¾öÀ翵 ±³¼ö(°æÈñ´ëÇб³)
15:00-15:20 Discussion  
15:20-15:35 Coffee Break  
Session ¥¸ ±âÃÊ/Áß°³ ¿¬±¸(Basic Research/Translational Research)
ÁÂÀå: È«¼ººó(ÀÎÇÏÀÇ´ë), °íÁøÈ£(¿¬¼¼¿øÁÖÀÇ´ë)
15:35-16:00 The Past, Present and Future in Space Medicine and Biology ±èÇö¿ì ±³¼ö(KAIST)
16:00-16:25 ±¹¿Ü: ¾ÏÁ¨ - ³ìÈ­º» ÁøÇà UCB(·Î¸ð¼ÒÁÖ¸¿ °³¹ß»ç) Dr. Cesar Libanati(¾ÏÁ¨)
16:25-16:45 Discussion